Analyst firms · Morgan Stanley · SOPH

Morgan Stanley SOPH price target and rating history

SOPHiA GENETICS SA (SOPH) · Technology

Morgan Stanley rates SOPHiA GENETICS SA (SOPH) Equal-Weight with a $5 price target, as of its latest action on Aug 7, 2024. It has published 3 rating actions on SOPH since August 2021, including 0 upgrades and 1 downgrade.

Current rating
Equal-Weight
Price target
$5
Median target, all firms
Too few
Actions on SOPH
3

Morgan Stanley price target on SOPH

$24$15$520222023202420252026
Morgan Stanley price target on SOPH, each point a stated target, August 2021 to August 2024.

Every Morgan Stanley rating on SOPH

Questions about Morgan Stanley and SOPH

What is Morgan Stanley's price target for SOPH?
Morgan Stanley's latest stated price target for SOPHiA GENETICS SA (SOPH) is $5, from its action on Aug 7, 2024.
What is Morgan Stanley's rating on SOPH?
Morgan Stanley rates SOPH Equal-Weight, a neutral rating, as of Aug 7, 2024.
When did Morgan Stanley last change its view on SOPH?
On Aug 7, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $10 to $5.

All Morgan Stanley ratingsSOPH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.